EZH2 and central nervous system cancer: First, EZH2 expression in sh-DLGAP1-AS1 transfected glioma cells (including sh-DLGAP1-AS1-1 and sh-DLGAP1-AS1-2) or sh-DLGAP1-AS1 together with miR-1297 inhibitors was explored using western blots and qRT-PCR.